Standard Drug Discovery and Development

$1 to $2 billion

Cost of a new drug development

10 to 15 years

To develop a new drug

1:10k

Success rate

We can reduce those numbers to

$250k – $50M

Cost of a new drug development

4 to 5 years

To develop a new drug

3:10

Success rate

OUR APPROACH

Artificial Intelligence

Propietary Databases of Chemical Structures

Scientific Expertise

Learn about our Unique Approach

Our Directions of Work

Proprietary pipeline

Proprietary pipeline

PARTNERSHIP

Our performance indicators

12%

of our performed projects have
reached Clinical Phase 2

 

29%

of our projects have a positive
  in vitro lead

We cooperate with

LATEST NEWS

SOM Biotech at the FDA Workshop
SOM Biotech attended the FDA Workshop
December 10, 2019

SOM Biotech attended the FDA Workshop “Repurposing Off-Patent Drugs: Research & Regulatory Challenge” on December 5th -6th– in Rockville, USA. The workshop aimed at exploring opportunities and challenges in assessing the safety and efficacy of repurposed drugs, as well as exploring several drug development pathways for treatments, with a specific ...

SOM Biotech at the 10th Drug Discovery Innovation Programme
November 29, 2019

SOM Biotech participated in the 10th Drug Discovery Innovation Programme that took place on November 28th -29th- in Barcelona, Spain. Luca Signorile – Computational Chemist of SOM Biotech –performed the presentation on the topic “Re-Discovering Drugs: Advantages, Perspectives, and the role of AI.” During his speech, he gave an insight ...

SOM Biotech at the Clinical Trials Europe 2019 conference
November 27, 2019

SOM Biotech has participated in the “Clinical Trials Europe 2019” conference, that took place on November 19th -21st- in Barcelona, Spain. The “Clinical Trials Europe 2019”, one of the leading platforms to build partnerships to develop clinical trials, attracts a wide range of innovative research centers and business development teams ...

SOM Biotech at the 10th World Orphan Drug Congress 2019
November 15, 2019

SOM Biotech participated in the World Orphan Drug Congress Europe 2019 on November 12th -14th– in Barcelona, Spain, where the company was a Showcase Sponsor. Raul Insa – CEO of SOM Biotech – presented “Case study: Systematic drug re-innovation and clinical evidence in orphan diseases”. SOM Biotech shared its latest ...

SOM Biotech at European Conference on Recent Advances in Lysosomal Diseases
November 4, 2019

Gal·la Pericot, R&D Manager at SOM Biotech, attended the European Conference on Recent Advances in Lysosomal Diseases, which took place on 24-25 October 2019 in London, UK. The main objective of the conference was sharing of innovative knowledge on the development of new therapeutic modalities for treating disorders linked to the ...

SOM Biotech at Bio-Europe 2019
October 24, 2019

SOM Biotech will participate in the 25th Annual International Partnering Conference “Bio-Europe” on November 10th -13th– in Hamburg, Germany. The conference, Europe´s largest life science partnering venue, is one of the most relevant events to meet with world-leading life science partners, investors, and industry experts. Raul Insa – CEO of ...

SOM Biotech at the 19th Annual Schrödinger European User Group Meeting
October 22, 2019

Luca Signorile, the Senior Computational Chemist at SOM Biotech, participated in the 19th Annual Schrödinger European User Group Meeting, that took place in Berlin on September 25th-27th. The Meeting aimed at illustrating how the capabilities of the Schrödinger software can be efficiently applied to drug discovery to increase research productivity. ...

Advisor to the Board of Directors of SOM Biotech ran the third annual Bay Area Fox Trot 5K Run/Walk for Parkinson’s Research
October 18, 2019

 Dr. Joaquim Trias, Advisor to the Board of Directors of SOM Biotech ran the third annual Bay Area Fox Trot 5K Run/Walk for Parkinson’s Research, last October 13th Sunday in San Mateo. The run was organized by The Michel J. Fox Foundation, a prestigious organization launched in year 2000 by ...